During today's Union Budget, Finance Minister Nirmala Sitharaman announced multiple initiatives and a staggering ₹1,62,671 crore to increase agricultural production in the country

Sitharaman, who was presenting her ninth consecutive budget, said the government will support the growth of high-value crops such as coconut, sandalwood, cocoa and cashew in coastal regions, agarwood in the North East and nuts,s including walnuts, almonds and pine nuts.

Dedicated programmes will focus on rejuvenating old orchards, expanding high-density cultivation and promoting value addition by engaging rural youth, while new coconut promotion schemes aimed at boosting productivity will be launched.

She noted: "India is the world’s largest producer of coconuts. About 30 million people, including nearly 10 million farmers, depend on coconuts for their livelihood. To further enhance competitiveness in coconut production, I propose a Coconut Promotion Scheme to increase production and enhance productivity through various interventions 16 including replacing old and non-productive trees with new saplings/plants/varieties in major coconut growing states.”

And health experts across the country say that an increase in consumption of these food items can significantly help improve your health.

Dr Sunil Kutty, Director and Consultant Brain and Spine Surgeon, NewEra Hospitals, Navi Mumbai, exclusively told Healthandme: "The Union Budget emphasises improving national nutrition and food security, recognising that better diets are foundational to health and well‑being.

"By strengthening food systems, supporting high‑value crops and enhancing access to nutrient‑rich foods, the government aims to reduce malnutrition, micronutrient deficiencies and diet‑linked diseases like Type-2 diabetes, obesity, and cardiovascular diseases. Integrating nutrition‑focused initiatives with healthcare can lower the overall burden of non‑communicable conditions and improve immunity, especially among children, women and vulnerable groups.

"These measures also support rural livelihoods, increasing access to affordable, healthy food across socio‑economic groups, contributing to long‑term health outcomes and reduced healthcare costs."

Coconut: Prevents Cell Damage And Packed With Essential Minerals

When eaten in moderation, coconuts offer healthy fats (MCTs), fibre, manganese, copper, iron, potassium as well as ample of antioxidants. Potassium helps balance sodium levels in the body and potentially lowers blood pressure, while the fruit's high fibre content supports bowel health and prevents constipation.

Coconuts are also especially high in manganese, which is essential for bone health and the metabolism of carbohydrates, proteins, and cholesterol. Along with this, they’re also rich in copper and iron, which help form red blood cells, as well as selenium, an important antioxidant that protects your cells and reduces cell damage which can prevent future cancer development.

A 2020 case study found that supplementing with coconut oil helped lower blood sugar levels in a person with diabetes, a condition characterized by unstable blood sugar levels. The researchers suggest that these effects may be due to the coconut’s anti-inflammatory properties and antioxidant content.

A 2024 animal study also found that consuming coconut water after eating could help manage blood sugar levels. This could be due to bioactive compounds like ellagic acid, butin, and quercetin, among others.

Sandalwood: Skin Benefits and Anxiety Reduction

Sandalwood offers benefits for skin health (acne, ageing, brightening), mental well-being, aid sleep, and possesses anti-inflammatory, antiseptic as well as antibacterial properties, making it useful for skin irritations, respiratory issues, and even potentially lowering blood pressure.

A 2017 Sigma study suggests that lavender, sandalwood, and orange-peppermint aromatherapy helped reduce self-reported feelings in anxiety of 87 women undergoing a breast biopsy.

In a 2016 pilot study published in NPC of 32 people in Vienna, Austria, participants inhaled lavender and sandalwood oil. The study found that the participants’ blood pressure levels were lower and that the cortisol levels in their saliva were lower after the aromatherapy.

Cocoa: Boosts Heart Health

While cocoa is most famous for its role in chocolate production, it is also packed with polyphenols and reduces high blood pressure by improving nitric oxide levels.

Researchers have previously linked polyphenols to numerous health benefits, including reduced inflammation, lower blood pressure and better heart health. It also contains flavanols, which have potent antioxidant and anti-inflammatory effects.

The flavanols in cocoa also improve nitric oxide levels in the blood, which can enhance the function of the blood vessels and reduce blood pressure.

Nuts: Improve Overall Health

Over time, this can improve artery health, lower bad LDL cholesterol, and reduced risk of blood clots, with varieties like almonds, walnuts, and pistachios providing unique nutrients like omega-3s, antioxidants and selenium.

Lastly, Pattabhi Rama Rao, Managing Director, Gourmet Popcornica also noted to Healthandme: "These measures, combined with stronger market linkages and local enterprise development, can make wholesome foods more affordable and accessible, directly supporting better nutrition and overall public health outcomes across the country. Not just this, farmers being able to access equitable income will enable them to access high-quality, nutritious food.

"By prioritising high-value and nutritious crops like coconut, cashew, cocoa, and walnuts, the government is not just enhancing farmers’ incomes but also ensuring that healthier, nutrient-rich foods are more widely available to the public.

"Diversifying production through fisheries, livestock, and region-specific crops, like maize in Andhra Pradesh and Chhattisgarh, will improve access to proteins, healthy fats, and essential micronutrients, which are vital for balanced diets.

Cancer, a rare occurrence? Unfortunately, not anymore. According to recent findings from an analysis published in The Lancet, cancer is one of the top 10 causes of death among Indian children. This is an alarming statistic, signalling an under-recognised public health problem. Data in the Global Burden of Disease Study 2023 noted that even as infectious diseases decline, noncommunicable diseases like cancer are emerging as a serious threat to child survival and well-being. In India, this epidemiological shift is particularly concerning in the context of childhood cancers. Despite being rare, they are highly treatable when detected in the early stages—yet most cases are diagnosed late.

As per the Indian Council of Medical Research’s National Centre for Disease Informatics and Research (ICMR-NCDIR), childhood cancers accounted for 3–5 per cent of cancer cases reported in India in 2022. The country sees an estimated 50,000 to 60,000 cases every year among children aged 0–14 years. This makes it one of the highest burdens globally. In 2023, 377,000 cases of childhood cancer were reported globally, along with 144,000 deaths, according to The Lancet research paper.

Read more: 3 Children In Every 4 Minutes Are Diagnosed With Cancer, That's What Makes Awareness Important Says Doctor

Hidden cancer burden in India

When it comes to childhood cancers in India, leukaemia, or blood cancers, are the most common, followed by lymphomas and tumours of the central nervous system. Collectively, these categories comprise most cases of childhood cancers in the country. The statistics vary across regions, with Delhi reporting the highest number of cases due to better diagnostic facilities. However, experts believe that the actual burden is likely to be much higher. Incomplete cancer registration and limited access to proper diagnostic facilities in underserved and rural areas are to blame for delayed diagnosis.

Why is childhood cancer detected late in India?

Experts say that cancer deaths in India can largely be attributed to delayed diagnosis. Early symptoms of cancer in children include fatigue, fever, unexplained weight loss, and swelling in certain body parts. These symptoms are often overlooked, leading to delays at multiple levels. According to the ICMR 2022 factsheet, a significant proportion of children reach hospitals only at advanced stages of the disease. By then, treatment becomes more complex, more expensive, and less likely to succeed.

Access to cancer care for children

Access to cancer care for children is uneven in India. Paediatric oncology services are largely limited to hospitals in tier-one cities, forcing families from rural areas and smaller towns to travel in order to access proper treatment. This imbalance results in delayed care, especially for economically vulnerable families. Financial limitations are another barrier in the process—even if treatment costs are subsidised, expenses such as travel, accommodation, and loss of income can be overwhelming.

Read more: 41 million children aged 5-19 living with high BMI in India: Study

Irregular survival patterns

Globally, survival rates for childhood cancers exceed 80 per cent in high-income countries. In India, outcomes are uneven. The ICMR 2022 factsheet noted that survival depends on the stage of diagnosis, type of cancer, and where the child is treated. Hospitals in India are reporting improving survival rates for certain forms of cancer, such as acute lymphoblastic leukaemia. The ICMR factsheet also highlights the need for a dedicated approach to paediatric cancer care, including better infrastructure, trained doctors, and stronger referral systems.

Indian weddings are a global sensation for all the taam-jhaam—the outfits, the music, the madness, and the unmatched vibe. In an ever-evolving culture, several new trends become a part of the wedding buzz in India. At a time when weight-loss drugs are the talk of the town, it is no surprise that they, too, have joined the list of new must-haves for Indian brides. For many soon-to-be brides and grooms, the pressure to look a class apart is always high. Amid the madness of wedding preparations, brides and grooms often miss the gym—weight-loss drugs come to their rescue.

India's Mounjaro brides

Clinics in metropolitan cities like Delhi and Mumbai are introducing weight-loss treatments into their traditional pre-bridal and bridal packages. Bridal packages initially focused on hair care, skincare, hair styling, and grooming—but they have now expanded to include shots of Mounjaro, a popular weight-loss drug. Some wellness centres in the city have advertised that they offer customised programmes combining workout routines, nutrition, and medication to help clients achieve desired results.

Doctors have noticed a clear rise in such inquiries. Several specialists report that a significant portion of their patients seeking obesity treatments are engaged couples working within a fixed timeline. While medical professionals acknowledge this demand, many emphasise that such treatments should only be prescribed when medically appropriate, rather than purely for cosmetic reasons.

Read more: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

The pressures of looking good at a wedding

Weddings in India are deeply rooted in tradition, elaborate, and often burdened by societal expectations around appearance. As a result, many resort to glycolic treatments, injections of Mounjaro, and sometimes even facial procedures for a bridal glow. However, weight-loss drugs serve a different purpose—they can boost a bride's confidence by helping her feel more comfortable in her own skin.

Others share similar experiences. Some individuals admitted that concerns about body image, often influenced by family expectations or societal standards, played a major role in their decision. In certain cases, weight became a factor in arranged marriage discussions, pushing individuals to seek faster solutions. However, most discontinued the injections shortly after their weddings.

Why are weight-loss drugs becoming so popular?

According to experts, the growing popularity of weight-loss drugs is linked to their increased availability. Globally, pharmaceutical companies have introduced their own versions of obesity treatments in India, and demand has risen drastically. At the same time, more affordable alternatives are being introduced by manufacturers to make these drugs accessible to a wider audience.

A word of caution

Despite the surge, experts warrant caution. Weight-loss drugs are intended to help clinically obese or significantly overweight individuals, as well as patients with type 2 diabetes and hypertension. These drugs are not meant to act as quick fixes for short-term aesthetic goals. Experts, therefore, stress the importance of using these drugs under expert guidance and supervision.

Misuse of weight-loss drugs

Doctors are also concerned about the misuse of weight-loss drugs—health authorities have started monitoring the sale and promotion of such medication, especially the cheaper versions on the market. Experts say that relying solely on these drugs instead of making essential lifestyle changes may not lead to sustainable results. For many, the appeal lies in convenience—maximum benefits with minimal effort. While these drugs may fit into a hectic routine, doctors continue to emphasise the need for a balanced approach to weight loss.

The UK National Health Service (NHS) is soon expected to roll out free weight-loss Wegovy jab to over a million people in England at risk of heart attacks and strokes.

The move is based on the recommendation of the National Institute for Health and Care Excellence (NICE), which said that overweight people with heart problems, or serious circulation problems in their legs, should have the weekly jab "as an extra layer of protection".

Developed by Danish drugmaker Novo Nordisk, Wegovy is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving the weight-loss drug Wegovy sustained weight loss for up to four years.

"We know that people who have already had a heart attack or stroke are living with real fear that it could happen again. The evidence from the clinical trial is compelling. It showed that people taking semaglutide alongside their existing heart medicines were significantly less likely to have another heart attack or stroke,” said Helen Knight, from NICE.

"Today's decision gives thousands of people in that situation an extra layer of protection, on top of the medicines they are already taking," she added.

Also read: Foundayo: US FDA Approves Eli Lilly’s GLP-1 Weight Loss Pill

Wegovy and Heart Risk

A November 2023 study, published in the New England Journal of Medicine, elicited a randomized clinical trial of tens of thousands of people, in which Wegovy - alongside existing heart medicines - was linked to a 20% reduced risk of heart attacks and strokes.

Importantly, benefits were seen early in the clinical trial, before significant weight loss occurred, suggesting the drug works directly on the heart and blood vessels, not just through weight loss, as per the NICE

The BBC reported that the UK faces a significant heart disease burden, and every year:

100,000 people get hospitalized due to heart attacks,

100,000 people experience a stroke

350,000 people live with peripheral arterial disease.

Sharon Hodgson, the health minister, said weight-loss drugs were a “gamechanger” and giving them to people at risk of heart attacks and strokes would be a “lifesaver”.

Also read: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

Wegovy Is Top Weight-Loss Choice for US Teens

Only Wegovy has been approved by the US FDA for children aged 12 and older who are living with obesity. Since the approval in late 2022, the prescriptions have surged.

According to health data company Truveta, which reviewed medical records from 30 US health systems, prescriptions for Wegovy among teens jumped by 50 percent in 2024—rising from 9.9 per 100,000 adolescents in 2023 to 14.8 per 100,000 in 2024.

The first quarter of 2025 showed another increase, with the rate reaching 17.3 per 100,000.